Investigations Blog
322 total results. Page 13 of 13.
D. Jacques Smith, Randall A. Brater, Stephanie Trunk, David S. Greenberg, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Randall A. Brater, Michael F. Dearington
The Office of Inspector General for the Department of Health and Human Services recently published its Semiannual Report to Congress, for the period April 1 to September 30, 2018.
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
At an FCPA conference on November 29, Deputy Attorney General Rod Rosenstein announced revisions to DOJ’s policy regarding pursuit of individuals involved in corporate wrongdoing. The current policy, memorialized in the 2015 “Yates Memo,” instructed that, “[t]o be eligible for any cooperation credit
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
Federal Court Throws Out False Claims Act Retaliation Claim Filed Against CEO in Individual Capacity
D. Jacques Smith, Randall A. Brater, Michael F. Dearington
A federal district court in the Southern District of New York dismissed claims filed against a CEO in his individual capacity under the False Claims Act’s anti-retaliation provision, and also rejected an alter-ego theory of liability.
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Randall A. Brater, Michael F. Dearington
Earlier this week, in Potts v. Center for Excellence in Higher Education, the Tenth Circuit held “that the False Claims Act’s anti-retaliation provision unambiguously excludes relief for retaliatory acts occurring after the employee has left employment.” 2018 WL 5796963, — F.3d — (10th Cir. Nov. 6,
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Arent Fox is pleased to announce the launch of the Investigations Blog, a dedicated resource for legal updates and analysis on key enforcement news for companies and executives in highly regulated industries.
D. Jacques Smith, Randall A. Brater, Nadia Patel
In a recent decision, the Sixth Circuit adopted an objective intent standard: an employee alleging constructive discharge in violation of the False Claims Act need not prove that the employer took actions designed to force the employee to quit.
D. Jacques Smith, Randall A. Brater
A development out of the Ninth Circuit makes relators more likely to qualify as an original source under the False Claims Act and thus survive the public disclosure bar.
D. Jacques Smith, Randall A. Brater, Nadia Patel
The latest False Claims Act settlements indicate that the Anti-Kickback Statute continues to be an enforcement priority and a key tool for identifying and prosecuting healthcare fraud.
D. Jacques Smith, Stephanie Trunk
Attorney General Jeff Sessions announced the launch of the Prescription Interdiction & Litigation Task Force, which will use criminal and civil law enforcement tools to combat the nation’s opioid epidemic, specifically targeting drug manufacturers and distributors.
D. Jacques Smith, Michael F. Dearington, Randall A. Brater
Three Department of Justice memoranda recently emerged that shed light on DOJ enforcement policies.
D. Jacques Smith, Randall A. Brater, Michael F. Dearington
A federal district court in Florida earlier this month reversed a jury verdict and vacated a $350 million False Claims Act award, joining the growing number of courts to strictly apply the materiality standard set by the US Supreme Court.
D. Jacques Smith, Randall A. Brater, Michael F. Dearington
The Department of Justice recently published its annual False Claims Act (FCA) recoveries statistics for Fiscal Year 2017, reporting $3.7 billion in FCA settlements and judgments in FY 2017.